Ortho Clinical Diagnostics today announced it will present seven scientific posters on its assays and display six products at its booth at the 2016 American Association for Clinical Chemistry (AACC) annual meeting. The conference will be held July 31 - August 4 in Philadelphia's Pennsylvania Convention Center. Ortho's posters will address a range of important tests, both marketed and in-development for clinical labs, including HIV, Chagas disease and thyroid function.
"Ortho is focused on expanding its assay portfolio and creating laboratory technology that features full testing automation and optimizes the power of informatics," said Karen Davis-Fleischer, vice president and head of business fields -- Clinical Labs Menu, for Ortho. "We look forward to sharing information on the development of our assays and showcasing our most recent innovations, which help enable our customers to reduce turnaround times and broaden their testing menus."
The posters Ortho will display at the conference are:Evaluation of the Performance of the VITROS® Immunodiagnostic Products HIV Combo Assay* at Two European Trial Sites Poster Session: August 3 from 9:30 a.m. to 5 p.m.; Infectious Disease (13) Author Presentation: 12:30 - 1:30 p.m. Presenter: Paul Contestable, principal scientist, Ortho Clinical Diagnostics Development of a High Sensitivity Prototype Assay* for Thyroid Stimulating Hormone Poster Session: August 2 from 9:30 a.m. to 5 p.m.; Endocrinology/Hormones (04) Author Presentation: 12:30 - 1:30 p.m. Presenter: Phil Hosimer, senior principal scientist, Ortho Clinical Diagnostics Development of an Enhanced Chemiluminescent C-peptide Assay* Poster Session: August 2 from 9:30 a.m. to 5 p.m.; Endocrinology/Hormones (04) Author Presentation: 12:30 - 1:30 p.m. Presenter: Holly Groth, staff scientist, Ortho Clinical Diagnostics Standardization and Harmonization of Ortho Clinical Diagnostics Thyroid Function Tests Poster Session: August 2 from 9:30 a.m. to 5 p.m.; Endocrinology/Hormones (04) Author Presentation: 12:30 - 1:30 p.m. Presenter: Chris Thomas, principal scientist, Ortho Clinical Diagnostics Evaluation of the Performance of the New VITROS® LDHI Assay Slide Poster Session: August 3 from 9:30 a.m. to 5 p.m.; Proteins/Enzymes (19) Author Presentation: 12:30 - 1:30 p.m. Presenter: Scott Hewitson, senior scientist, Ortho Clinical Diagnostics Performance of a Prototype T. cruzi Assay* for the Detection of Chagas Disease Poster Session: August 3 from 9:30 a.m. to 5 p.m.; Infectious Disease (13) Author Presentation: 12:30 - 1:30 p.m. Presenter: Sue Danielson, research fellow, Ortho Clinical Diagnostics Comparative Study of Six Sigma Assay Performance on VITROS® Systems Poster Session: August 3 from 9:30 a.m. to 5 p.m.; Management (15) Author Presentation 12:30 - 1:30 p.m. Presenter: Andy Kirsch, manager, systems support and field triage, Ortho Clinical Diagnostics
Products on display in Ortho's booth (No. 1100) at AACC will include Ortho's flagship Integrated Clinical Chemistry and Immunodiagnostic Systems and the Nephrocheck® Test. Ortho will also highlight the company's transfusion medicine instrument, The ORTHO VISION® MAX.**
Visitors to the booth will also be able to witness how the enGen Laboratory Automation system, used in combination with the VITROS® Systems and informatics solutions, helps clinical labs automate, streamline and standardize workflow. Auto-verification improves security, increases walk-away time and diminishes costs, allowing lab professionals to more efficiently manage testing.
"Every product and service that Ortho offers reflects our commitment to reimagining what's possible in labs today," said Michael Iskra, president, North America Commercial Operations. "Lab professionals are challenged to do more with limited resources and increasing demand. We're redefining possibilities, offering comprehensive, fully integrated laboratory solutions that enhance the total value of instrument ownership."
The company will also host an invitation-only customer event at the Franklin Institute on Tuesday, August 2, from 5 p.m. to 9:30 p.m., featuring a session on empowering lab directors to work effectively with C-level hospital executives, as well as a lecture on the changing landscape of heart failure biomarkers.
Another highlight of Ortho's presence at the meeting will be an in-booth virtual reality lab visualization station. Using the latest 3D technology, visitors will work with our design team to custom build their own dream laboratories. They'll then tour the creations via virtual reality, learning how proprietary Ortho technology allows labs to grow and change as their needs do. The booth will also feature a theatre with a rotating roster of key opinion leader presentations and a lab informatics station.
*In development -- Not approved or cleared in the United States.
**Pending 510(k) clearance
About Ortho Clinical Diagnostics Ortho Clinical Diagnostics is a global leader of in vitro diagnostics serving the clinical laboratory and immunohematology communities. Across hospitals, hospital networks, blood banks and labs in more than 120 countries, Ortho's high-quality products and services enable health care professionals to make better-informed treatment decisions. For the immunohematology community, Ortho's blood typing products help ensure every patient receives blood that is safe, the right type and the right unit. Ortho brings sophisticated testing technologies, automation, information management and interpretation tools to clinical laboratories around the world to help them run more efficiently and effectively and improve patient care. Ortho's purpose is to improve and save lives with diagnostics, and it does that by reimagining what's possible. This is what has defined Ortho for more than 75 years, and it's what drives Ortho forward. For more information, visit www.orthoclinicaldiagnostics.com. © Ortho Clinical Diagnostics 2016